
Aptuit, an Evotec Company. A drug discovery & development solutions company with a global presence. Follow @Evotec to keep up-to-date #researchneverstops
Greenwich, CT
Joined October 2010
- Tweets2K
- Following28
- Followers827
- Likes41
Aptuit retweeted
Join Cyprotex at #ISSX2019 from the 28-31 July in Portland, Oregon. Come meet our team Phil Butler, Head of ADME, and Directors of Business Development Gavin Magnuson and Roger Dinallo at booth 114. Contact [email protected] to schedule a meeting.
@Evotec @aptuit
Aptuit retweeted
Our June newsletter is just out! Find out all the latest news from @cyprotex including our new mitochondrial respiratory complex assay. ow.ly/Z7ZL50uNkCC @Evotec @aptuit
Aptuit retweeted
ADME-Tox experts are gathering today in Boston for @cyprotexplc ADME-Tox Lead Optimization Workshop. Speakers from Genentech, Pfizer, Celgene, BMS, Takeda, Sage Therapeutics and @cyprotexplc will be presenting on their latest research. ow.ly/rk3m30mSTg6 @EvotecAG @aptuit
Aptuit retweeted
The Business Development Team of the Year goes to Evotec's business development team! Well done all of you! #ScripAwards2018
Aptuit retweeted
@EvotecAG wins award for Sustained Excellence at Deloitte's Technology #Fast50 | Very proud for the prestigious award, with which Deloitte honours the fastest-growing innovation drivers within the technology sector @DeloitteDE #Deloitte @cyprotexplc @aptuit
Aptuit retweeted
Access to talent and retention to talent is one of the biggest advantages of starting out in Europe - Werner Lanthaler @EvotecAG @lundbeckfonden @NovoVentures @JNJInnovation @novonordisk @GalapagosNV #BIOEurope
Aptuit retweeted
Save a seat in our #BIOEurope opening plenary with Mette Kirstine Agger - @lundbeckfonden Thomas Dryberg @NovoVentures Sir Harpel Kumar - @JNJInnovation Marcus Schindler @novonordisk Werner Lanthaler - @EvotecAG Onno van de Stolpe - @GalapagosNV
Aptuit retweeted
We are happy to announce our second project to be developed under our partnership with @EvotecAG: a novel therapeutic approach to treat glaucoma. The project comes from the lab of Dr. Jeremy Sivak at @UHN @KrembilRI bit.ly/2RqXR0g #glaucoma
Aptuit retweeted
Interested in joining our toxicology group at @AlderleyPark in the UK? We have an exciting opportunity for a study manager specialising in in vitro toxicology. Visit our careers page to find out more. ow.ly/SGqW30lQw3w @cyprotexplc @aptuit @EvotecAG
Aptuit retweeted
Thanks to Evotec for hosting a fantastic event. Some brilliant science and presentations
Aptuit retweeted
Don't miss Dr Rob Elsby's presentation 'Transporter DDI: An Evaluation of Approaches and Methodologies' at #DDI-2018 in #Seattle tomorrow at 8:05am.
ow.ly/TT0I30kvNG1
Aptuit retweeted
Find out how 3D cell-based cardiac models can be used to determine functional and structural cardiotoxicants. Read our latest blog and download our poster. ow.ly/z4DS30kvNV9 @EvotecAG @aptuit
Aptuit retweeted
Our headquarter in #Hamburg, #Germany, is seeking a Research Scientist to apply imaging and analysis technologies to understand the pathology of various diseases. If you hold a PhD in biophysics, bioinformatics or related fields, please apply here #Jobs
recruitment.evotec.com/Vacan…
Aptuit retweeted
Next week, Cyprotex will be exhibiting at HT-ADME in Boston. Arrange a meeting with our US team by contacting [email protected] @EvotecAG @aptuit
Aptuit retweeted
Last chance to register for our complimentary in vitro toxicology seminar in Basel on 21st June 2018. Reserve your place by contacting [email protected] ow.ly/rGaT30kswYD
Aptuit retweeted
We are looking forward to attending #ASM2018 and engaging with the infectious disease community. Meet with our scientific experts at booth #2733 or during the poster sessions.
Aptuit retweeted
Our CEO shares his thoughts on Evotec's collaboration with academic institutes to further drug discovery research through our BRIDGE initiative in the June @NatRevDrugDisc edition. Pick a copy compliments of @SpringerNature at #BIO2018.
Aptuit retweeted
Join us in Basel to learn about the latest in vitro techniques in toxicology. Dr Paul Walker, Head of Toxicology at Cyprotex, will be presenting on 21 June 2018. ow.ly/IfiA30k94tb Reserve your free place by contacting [email protected] @aptuit @EvotecAG
Aptuit retweeted
Don't miss Keynote Speaker, Dr Paul Walker, Head of Toxicology at Cyprotex, at the #ACTC2018 event in Cardiff tomorrow. ow.ly/ohDw30k6dn8 @EvotecAG @aptuit
























